Parabilis Medicines, Inc. (PBLS)
EBITDA
-$186.72M
TTM · Period ending: · USD

PBLS EBITDA
What is ebitda?
EBITDA is earnings before interest, taxes, depreciation and amortization. It is a measure of earnings, not cash flow.
Compare ebitda
PBLS ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -141,867,000 | |
| -114,328,000 |
Frequently asked questions: PBLS ebitda
What is Parabilis Medicines, Inc. (PBLS)'s current ebitda?
Parabilis Medicines, Inc. (PBLS)'s latest reported ebitda (TTM) is -$186.72M as of Sep 30, 2026. EBITDA is earnings before interest, taxes, depreciation and amortization. It is a measure of earnings, not cash flow.
How much historical ebitda data is available for PBLS?
Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s ebitda, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare PBLS's ebitda to peers or set an alert?
You can compare PBLS's ebitda directly against sector peers (LLY, JNJ, ABBV, MRK) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on PBLS delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance